Granules India Ltd. (GRANULES): Granules India Share Price Rises 2.68% as Market Cap Crosses Rs 21,003.27 Cr

Granules India Share Price is higher today, with the stock last traded at Rs 870.3, up 2.68% from the previous close of Rs 847.6. The company’s market capitalisation stands at Rs 21,003.27 Cr, placing this Granules India Share Price move in the context of a large-cap healthcare name. According to latest Univest data, the stock traded between Rs 845 and Rs 872.2 today after opening at Rs 848, while turnover stood at Rs 1.12 Cr.

This Granules India Share Price update is relevant because the move is visible in the market even though the data does not establish a company-specific catalyst. For readers following Granules India Stock News, the focus today is on price action, valuation and sector positioning rather than any unverified trigger. In the first part of the session, Granules India Share Price Today reflects steady buying interest around the opening band, and investors tracking Granules India Stock Analysis will likely compare that move with its earnings profile, peer set and healthcare industry backdrop. Univest is highlighting the same-day rise, the company’s market cap and the ratios that shape near-term attention.

Granules India Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 870.3
Previous Close	Rs 847.6
Today's Move	Rs 22.7 (+2.68%)
Open	Rs 848
High	Rs 872.2
Low	Rs 845
Turnover	Rs 1.12 crore
Market Capitalisation	Rs 21,003.27 crore
Market Cap Category	Large Cap

Granules India Ltd. (GRANULES) rose to Rs 870.3 from the previous close of Rs 847.6, a move of Rs 22.7 or 2.68%. The stock opened at Rs 848, reached a high of Rs 872.2, recorded a low of Rs 845.

Granules India Share Price Today shows a clear intraday gain of Rs 22.7, or 2.68%, from the previous close of Rs 847.6 to Rs 870.3. The stock opened at Rs 848, moved up to Rs 872.2 and was seen as low as Rs 845 during the trading day. This Granules India Share Price rise keeps the name among the more active healthcare counters in the Indian stock market today, even as the latest Univest figures do not point to a company-specific trigger. For investors scanning Granules India Stock News, the main takeaway is straightforward: price action improved, turnover remained modest at Rs 1.12 Cr, and the move is being watched as part of broader stocks in news coverage.

Granules India Ltd. (GRANULES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 21,003.27 crore
P/E Ratio	31.71x
P/B Ratio	4.29x
ROE	14.13%
ROCE	15.74%
EPS	Rs 26.73
Book Value Per Share	Rs 197.72
Dividend Yield	0.21%

Granules India Ltd. (GRANULES) fundamental metrics show P/E 31.71x, P/B 4.29x, ROE 14.13%, ROCE 15.74%. These figures provide context only and are not a buy or sell signal.

Granules India Ltd. has a market capitalisation of Rs 21003.27 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.71x, P/B at 4.29x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.13% and ROCE of 15.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 26.73, book value per share of Rs 197.72, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	31.71x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	4.29x
Benchmark Median P/B	2.92x
Company ROE	14.13%
Benchmark Median ROE	11.78%
Company ROCE	15.74%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 21,003.27 crore
Benchmark Median Market Cap	Rs 674.09 crore

Granules India Ltd. (GRANULES) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Granules India Ltd. (GRANULES) has a P/E ratio of 31.71x, which is below the benchmark median of 32.83x, a difference of -3.41%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Granules India Ltd. (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 11.78%, a difference of +19.95%. Granules India Ltd. (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.65%, a difference of +15.31%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39

Granules India Ltd. (GRANULES) has a P/E ratio of 31.71x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.13% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Granules India Ltd. (GRANULES) has a market capitalisation of Rs 21,003.27 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Granules India

• Granules India Share Price is up 2.68% today and is trading above the previous close of Rs 847.6.
• The stock touched Rs 872.2 and traded with a market cap of Rs 21,003.27 Cr, keeping it visible in market movers.
• Granules India Share Price Today is being assessed against a P/E of 31.71, P/B of 4.29 and EPS of Rs 26.73.
• ROE of 14.13% and ROCE of 15.74% place the name in a reasonably healthy return bracket for the sector.
• Peers in pharmaceuticals give investors a clear frame for Granules India Share Price news and relative valuation checks.

About Granules India

Granules India Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s market presence is reflected in its Rs 21,003.27 Cr market capitalisation, and its Granules India Share Price moves are therefore followed closely by investors who track Indian stock market healthcare names. The latest Univest figures show a business profile that can be assessed through valuation ratios, earnings per share, book value and return metrics rather than only through short-term market moves.

For readers searching Granules India Share Price Live, the company sits in a sector where peer comparison matters because pricing varies widely across manufacturers and branded pharma names. Granules India Share Price Today therefore gets attention not just as a one-day move, but as part of a broader company overview, financial analysis and sector analysis process on Univest.

Frequently Asked Questions

Why is Granules India Share Price rising today?

Ans. Granules India Share Price is up 2.68% today, but the market data does not establish a company-specific catalyst. The move is visible through the day’s price action, market cap of Rs 21,003.27 Cr and intraday range.

What is Granules India Share Price Today?

Ans. Granules India Share Price Today is Rs 870.3, compared with the previous close of Rs 847.6. The stock opened at Rs 848 and touched Rs 872.2 during the trading day.

How much did Granules India stock gain today?

Ans. Granules India stock gained Rs 22.7, or 2.68%, from the previous close. That move has kept Granules India Share Price in focus for traders watching healthcare names in the Indian stock market.

What is the market capitalisation of Granules India?

Ans. Granules India has a market capitalisation of Rs 21,003.27 Cr. That places Granules India Share Price in the large-cap zone and above the sector median market cap across the same-industry benchmark.

How is Granules India valued on P/E and P/B?

Ans. Granules India trades at a P/E of 31.71 and a P/B of 4.29. The P/E is slightly below the sector median, while the P/B is above the sector median, so valuation looks mixed.

What do Granules India EPS, book value and dividend yield show?

Ans. Granules India reports EPS of Rs 26.73, book value of Rs 197.72 and dividend yield of 0.21%. These numbers help readers judge earnings power, accounting value and historical payout context.

How does Granules India compare with healthcare peers?

Ans. Granules India Share Price sits in the middle of its peer range on valuation. Its P/E is below Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals, while ROE and ROCE stay competitive versus several listed peers.

Should investors track Granules India Share Price on Univest?

Ans. Yes, investors can track Granules India Share Price on Univest for live price updates, valuation ratios, company news, sector context and peer comparison. It is useful for monitoring the stock without making assumptions about direction.

Track Granules India Share Price on Univest

Use Granules India Ltd. (GRANULES) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Granules India Share Price on Univest for live price updates, market cap context, valuation ratios, EPS, book value, dividend yield and sector benchmarks. Univest also helps readers follow Granules India Stock News, Granules India Latest News and Granules India Stock Analysis in one place.

Use Univest to review Granules India Share Price Today alongside peer comparison, industry context and key market insights whenever the stock is in focus.